Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Blood (2019) 134 (Supplement_1): 1484.

https://doi.org/10.1182/blood-2019-129832

Published: 2019

Journal Articles

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

Jing Yang, PhD, Zhiqiang Liu, PhD, Huan Liu, PhD, Jin He, Jianling Yang, PhD, Pei Lin, MDDM,MDC, Qiang WANG, PhD, Juan Du, PhD MD, Wencai Ma, Richard E Davis, BSPharm, MS, Robert Z. Orlowski, MD PhD, Jian Hou, MD, Qing Yi, MD PhD

Blood (2017) 130 (Supplement 1): 3043.

https://doi.org/10.1182/blood.V130.Suppl_1.3043.3043

Published: 2017

Journal Articles

Aggresive Lymphoma—Leukemia Presenting As a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

Rejin Kebudi, MD, Omer Gorgun, MD, Oner Dogan, MD

Blood (2017) 130 (Supplement 1): 5226.

https://doi.org/10.1182/blood.V130.Suppl_1.5226.5226

Published: 2017

Journal Articles

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Ming Hong, MD PhD, Shuai Wang, MD PhD, Han Zhu, MD, Rong Wang, Jianyong Li, MD PhD, Guangsheng He, MD PhD

Blood (2017) 130 (Supplement 1): 5230.

https://doi.org/10.1182/blood.V130.Suppl_1.5230.5230

Published: 2017

Journal Articles

Palliative Outpatient Care in Children with Hematologic Malignancies Compared to Solid Tumors

Michaela Kuhlen, MD, Jessica I Hoell, MD, Gabriele Gagnon, MD, Stefan Balzer, MD, Arndt Borkhardt, MD, Gisela Janßen, MD

Blood (2016) 128 (22): 5977.

https://doi.org/10.1182/blood.V128.22.5977.5977

Published: 2016

Journal Articles

Risk of Developing Second Cancers in Plasmacytoma in United States

Vivek Kumar, MD, Neha Chaudhary, MD, Vishangi Dave, MD, Abhinav B Chandra, MD MSc, FACP

Blood (2016) 128 (22): 4443.

https://doi.org/10.1182/blood.V128.22.4443.4443

Published: 2016

Journal Articles

CD26 Is a Novel Target for the Treatment of Tumor Progression and Its Related Osteolytic Bone Disease in Multiple Myeloma

Hiroko Nishida, MD, PhD, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, MD, PhD, Chikao Morimoto, MD, PhD, Michiie Sakamoto, MD, PhD, Taketo Yamada, MD, PhD

Blood (2015) 126 (23): 1809.

https://doi.org/10.1182/blood.V126.23.1809.1809

Published: 2015

Journal Articles

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

Julie A Ross, PhD, Todd E Druley, MD, PhD, Kimberly J Johnson, Rachel K. Fonstad, M.S., Julie von Behren, MPH, Beth Mueller, PhD, Susan Carozza, PhD, Eric J. Chow, MD, MPH, Colleen McLaughlin, PhD, Peggy Reynolds, PhD, Erin Fox, PhD, Scott Horel, Logan G. Spector, PhD

Blood (2013) 122 (21): 1395.

https://doi.org/10.1182/blood.V122.21.1395.1395

Published: 2013

Journal Articles

The Pan-PIM Kinase Inhibitor LGH447 Shows Activity In PIM2-Dependent Multiple Myeloma and In AML Models

Pablo D Garcia, PhD, John L Langowski, Ph.D., Jocelyn Holash, Ph.D., Matthew Burger, Ph.D., Richard Zang, Ph.D., Tatiana Zavorotinskaya, PhD, Christie Fanton, PhD, Abdel Saci, Ph.D., Joseph Growney, Ph.D., K. Gary Vanasse, M.D.

Blood (2013) 122 (21): 1666.

https://doi.org/10.1182/blood.V122.21.1666.1666

Published: 2013

Journal Articles

Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma–induced bone disease in a novel murine plasmacytoma xenograft model

W. Grady Gunn, Ulf Krause, Narae Lee, Carl A. Gregory

Blood (2011) 117 (5): 1641–1651.

https://doi.org/10.1182/blood-2010-09-308171

Published: 2011

Includes: Supplemental data

Journal Articles

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence

Joonseok Cho, Hongmei Shen, Hui Yu, Hongjie Li, Tao Cheng, Sean Bong Lee, Byeong Chel Lee

Blood (2011) 117 (4): 1156–1166.

https://doi.org/10.1182/blood-2010-04-279349

Published: 2011

Includes: Supplemental data

Journal Articles

Systemically Transplanted Human Bone Marrow Mesenchymal Stem Cells Primarily Traffic to Mesenteric Lymph Nodes

Xin Li, PhD, Wen Ling, MS, Sharmin Khan, MS, Yuping Wang, Ph.D., Angela Pennisi, MD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD, Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 2580.

https://doi.org/10.1182/blood.V116.21.2580.2580

Published: 2010

Journal Articles

Solitary Plasmacytoma. Presentation of 22 Cases of Two Centres from Buenos Aires, Argentina

Marta Dragosky, MD, Susana Alcaraz, MD, Isabel Anetta, MD, Ariel Corzo, MD, Laura Devotto, MD, Ernesto Gil Deza, MD, Patricia Luchetta, MD, Marisa Marquez, MD

Blood (2008) 112 (11): 5206.

https://doi.org/10.1182/blood.V112.11.5206.5206

Published: 2008

Journal Articles

Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner

Angela C. Hirbe, Özge Uluçkan, Elizabeth A. Morgan, Mark C. Eagleton, Julie L. Prior, David Piwnica-Worms, Kathryn Trinkaus, Anthony Apicelli, Katherine Weilbaecher

Blood (2006) 109 (8): 3424–3431.

https://doi.org/10.1182/blood-2006-09-048686

Published: 2006

Includes: Supplemental data

Journal Articles

Impact of Whole-Body Magnetic Resonance Imaging on Staging in Patients with Newly Diagnosed Plasma Cell Disease.

Martin Zoz, Andreas Baldauf, Anne Schipp, Jens Hillengass, Anthony D. Ho, Harmut Goldschmidt, Jochen Hansmann, Thomas Moehler

Blood (2006) 108 (11): 5061.

https://doi.org/10.1182/blood.V108.11.5061.5061

Published: 2006

Journal Articles

Downregulation of Receptor Activator of Nuclear Factor kB Ligand (RANKL) in Chronic Myeloid Leukemia Patients Receiving Imatinib Mesylate Is Dose-Dependent.

Francesco Albano, MD, PhD, Antonella Zagaria, PhD, Luisa Anelli, PhD, Maria Guastadisegni, PhD, Alessandra Pannunzio, PhD, Giuseppina Spinosa, MD, Mariano Rocchi, PhD, Vincenzo Liso, MD, Giorgina Specchia, MD

Blood (2006) 108 (11): 4786.

https://doi.org/10.1182/blood.V108.11.4786.4786

Published: 2006

NARROW

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

Aggresive Lymphoma—Leukemia Presenting As a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Palliative Outpatient Care in Children with Hematologic Malignancies Compared to Solid Tumors

Risk of Developing Second Cancers in Plasmacytoma in United States

CD26 Is a Novel Target for the Treatment of Tumor Progression and Its Related Osteolytic Bone Disease in Multiple Myeloma

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

The Pan-PIM Kinase Inhibitor LGH447 Shows Activity In PIM2-Dependent Multiple Myeloma and In AML Models

Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma–induced bone disease in a novel murine plasmacytoma xenograft model

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence

Systemically Transplanted Human Bone Marrow Mesenchymal Stem Cells Primarily Traffic to Mesenteric Lymph Nodes

Solitary Plasmacytoma. Presentation of 22 Cases of Two Centres from Buenos Aires, Argentina

Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner

Impact of Whole-Body Magnetic Resonance Imaging on Staging in Patients with Newly Diagnosed Plasma Cell Disease.

Downregulation of Receptor Activator of Nuclear Factor kB Ligand (RANKL) in Chronic Myeloid Leukemia Patients Receiving Imatinib Mesylate Is Dose-Dependent.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only